Causal factors for migraine in Mendelian randomization studies: a systematic review and meta-analysis.
Study Design
- 연구 유형
- systematic review and meta-analysis
- 중재
- Causal factors for migraine in Mendelian randomization studies: a systematic review and meta-analysis. None
- 대조군
- Placebo
- 효과 방향
- Mixed
- 비뚤림 위험
- Low
Abstract
BACKGROUND: Migraine is a familial, episodic disorder characterized by complex sensory processing dysfunction, with headache serving as its hallmark feature. While numerous risk factors have been proposed, the causal nature of these associations often remains ambiguous. Mendelian randomization (MR) represents a robust epidemiological framework that leverages genetic variants to infer causal relationships, thereby overcoming limitations of observational studies. This study systematically reviews and meta-analyzes MR evidence to elucidate bidirectional causal relationships between migraine and systemic diseases, identify novel risk determinants, and highlight critical gaps for future mechanistic investigations. METHODS: A comprehensive literature search was conducted across seven databases (PubMed, Embase, Cochrane Library, Web of Science, China National Knowledge Infrastructure, WanFang Data Knowledge Service Platform, and VIP China Science and Technology Journal Database) using predefined search strategies and exclusion criteria. The search time limit was from the construction of the database to July 3, 2024. Study eligibility was independently assessed by two reviewers, with data extraction processes adhering to STROBE-MR guidelines. Included studies were evaluated for quality using validated criteria, and relevant data (study design, participant demographics, genetic instruments, analytical methods, and outcomes) were systematically extracted. Data synthesis involved meta-analytical pooling of effect estimates using Review Manager 5.4, with forest plots generated to visualize results. Causal relationships were interpreted according to the WHO ICD-11 disease classification system, with subgroup analyses performed for migraine with aura (MWA) and migraine without aura (MOA). RESULTS: A total of 60 studies involving 331 MR analyses were included, revealing bidirectional causal relationships between migraine and multiple phenotypes: migraine was identified as a causal factor for 6 diseases (Alzheimer's disease, cervical artery dissection, venous thromboembolism, coronary artery disease, angina, large artery stroke), 3 behavioral habits (delayed age at first sexual intercourse, maternal smoking, reduced physical activity), 1 dietary intakes (alcohol consumption), and 3 physiological indicators (elevated interleukin-2, increased Body Mass Index, higher serum vitamin D levels) (p < 0.05). Conversely, 6 diseases (venous thromboembolism, breast cancer, insomnia, difficulty awakening, major depressive disorder, depression), 5 behavioral factors (television watching, smoking initiation, delayed AFS, more schooling, reduced physical activity), 4 dietary determinants (coffee, alcohol, cheese, salad intake), 13 physiological parameters (hemostatic, cardiovascular, metabolic, and genetic markers), and 1 gut microbiota taxon (LachnospiraceaeUCG001) were causal determinants of migraine risk (p < 0.05). Subtype-specific analyses showed MOA was causally associated with 4 diseases (AD, CeAD, CAD, LAS) and delayed AFS as an exposure, and influenced by breast cancer, celiac disease, TV watching, delayed AFS, increased schooling, and physiological parameters (DBP, PP, serum calcium, IGF-1) as an outcome; MWA demonstrated causal relationships with CeAD and LAS as an exposure, and associations with VTE, SLE, MDD, delayed AFS, coffee intake, and hemostatic markers as an outcome (p < 0.05 for all). CONCLUSION: This systematic review provides robust genetic evidence supporting bidirectional causal relationships between migraine and multiple phenotypes, including systemic diseases, behavioral habits, dietary factors, and physiological parameters. Subtype-specific analyses highlight distinct causal pathways for MOA and MWA, underscoring the clinical heterogeneity of migraine. These findings advance our understanding of migraine pathogenesis and inform precision medicine approaches, while also identifying novel therapeutic targets for this disabling condition. More data will be needed in the future to obtain a more specific assessment. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/PROSPERO/view/CRD42025636141, Identifier CRD42025636141.
Full Text
Figures
Figure 1
PRISMA flow diagram for the systematic review and meta-analysis of causal factors for migraine identified through Mendelian randomization studies.
flowchart
Figure 2
Forest plot summarizing the causal effect estimates of various risk factors on migraine from pooled Mendelian randomization analyses.
forest_plot
Figure 3
Subgroup analysis of genetically predicted metabolic factors and their causal associations with migraine risk.
forest_plot
Figure 4
Mendelian randomization results for the causal relationship between nutritional or dietary factors and migraine susceptibility.
forest_plot
Figure 5
Effect estimates for lifestyle-related causal factors on migraine, derived from instrumental variable analyses.
forest_plot
Figure 6
Causal associations between inflammatory biomarkers and migraine risk as determined by Mendelian randomization.
forest_plot
Figure 7
Forest plot of hormonal or reproductive factors and their genetically predicted causal effects on migraine.
forest_plot
Figure 8
Sensitivity analyses assessing pleiotropy and instrument validity for the migraine Mendelian randomization findings.
chart
Figure 9
Causal effect estimates for sleep-related traits on migraine risk from Mendelian randomization analysis.
forest_plot
Figure 10
Summary of genetically predicted psychiatric or neurological comorbidity factors and their causal links to migraine.
forest_plot
Figure 11
Mendelian randomization results for anthropometric measures and body composition as causal factors for migraine.
forest_plot
Figure 12
Pooled estimates examining the causal role of vascular or cardiovascular risk factors in migraine pathogenesis.
forest_plot
Figure 13
Leave-one-out or MR-Egger sensitivity analysis validating the robustness of key causal associations identified for migraine.
chart
Figure 14
Funnel plots assessing directional pleiotropy for the primary Mendelian randomization findings on migraine risk factors.
chart
Figure 15
Meta-analysis of multiple Mendelian randomization studies examining the same exposure-migraine relationship, showing consistency across datasets.
forest_plot
Figure 16
Stratified analysis of migraine subtypes (with and without aura) and their distinct causal factor profiles from Mendelian randomization.
forest_plot
Figure 17
Comprehensive overview mapping all identified causal factors for migraine organized by biological category and strength of evidence.
diagram
Figure 18
Summary evidence matrix or heat map of all Mendelian randomization-supported causal factors for migraine across the included studies.
chartTables
Table 1
| Study (first author, year) | Method | Theme | Ethnicity of exposure | Ethnicity of outcome | Whether causality exists | ||
|---|---|---|---|---|---|---|---|
| Forward | Reverse | Subtypes | |||||
| Peter Yin, 2017 ( | Two-sample unidirectional MR | Elevation of serum calcium levels by 1 mg/dL | European | European | No causal effect | Risk factor | Elevation of serum calcium levels by 1 mg/dL-MOA: risk factor |
| Johnsen, M. B, 2018 ( | One-sample unidirectional MR | Smoking | Norway | Norway | No causal effect | / | / |
| Daghlas, I, 2020 (1) ( | Two-sample unidirectional MR | AD, intelligence, brain volume | European | European | No causal effect | / | / |
| Daghlas, I, 2020 (2) ( | Two-sample bidirectional MR | Insomnia, difficulty awakening | European | European | No causal effect | Risk factors | / |
| Daghlas, I, 2020 (3) ( | Two-sample unidirectional MR | CAD, myocardial infarction, angina, AF | European | European | Protective factors: CAD, myocardial infarction, angina | / | MOA-CAD: protective factor |
| Emmanuel O. Adewuyi, 2020 ( | Two-sample bidirectional MR | Endometriosis | European (approximately 93%) and Japanese ancestries (from Australia, Belgium, Denmark, Iceland, Japan, the UK, and the USA) | European | No causal effect | No causal effect | / |
| Guo, Y, 2020 ( | Two-sample bidirectional MR | BP | European | European | No causal effect | Risk factors: SBP, DBP, PP | DBP-MOA: risk factors |
| Chu, S, 2021 ( | Two-sample bidirectional MR | Insomnia | European | European | No causal effect | Risk factor | / |
| Guo, Y, 2021 ( | Two-sample bidirectional MR | Hemostatic profile | European | European | No causal effect | Risk factors: FVIII activity, vWF levels, phosphorylated fibrinopeptide A | Fibrinogen levels-MWA: protective factor |
| Brittany L Mitchell, 2022 ( | Two-sample bidirectional MR | ICV | European | European | No causal effect | Protective factor | / |
| Chen, H, 2022 ( | Two-sample unidirectional MR | Coffee consumption | British | European | No causal effect | / | No causal effect |
| Daghals, I, 2022 ( | Two-sample unidirectional MR | CeAD, LAS | European | European | Risk factor: CeAD | / | MOA-CeAD: risk factor |
| Islam, M. R, 2022 ( | Two-sample bidirectional MR | T2D | European | European | No causal effect | No causal effect | / |
| Keon-Joo Lee, 2022 ( | Two-sample unidirectional MR | Stroke, ischemic stroke, hemorrhagic stroke | European | European | No causal effect | / | No causal effect |
| Mei-Jun Shu, 2022 ( | Two-sample unidirectional MR | Ischemic stroke | European | European | No causal effect | / | / |
| Peng-Peng Niu, 2022 ( | Two-sample bidirectional MR | Higher serum vitamin D levels | European | European | Risk factor | Protective factor | No causal effect |
| Reziya Abuduxukuer, 2022 ( | Two-sample bidirectional MR | IGF-1 | European (94.3%) | European | No causal effect | Protective factor | IGF-1-MWA: no causal effect |
| Shuai Yuan, 2022 ( | Two-sample bidirectional MR | Alcohol consumption, coffee consumption, smoking initiation, smoking index | European | European | Protective factor: alcohol consumption | Risk factors: smoking initiation | / |
| Bi, Y, 2023 ( | Two-sample unidirectional MR | Genetic instrumental variables for lipids and lipid modifying targets | N/A | European (92.55%) | / | Protective factor: APO-A1 | / |
| Chong Fu, 2023 ( | Two-sample bidirectional MR | Inflammatory cytokines | Finnish descent | European | Migraine-IL-2: protective factor | HGF-migraine: risk factor | / |
| Fang, T, 2023 ( | Two-sample unidirectional MR | Breast cancer | European | European | / | Risk factor | Breast cancer-MWA: no causal effect |
| Guo, X, 2023 ( | Two-sample bidirectional MR | Total cortical SA, average cortical thickness, GMV, WMH, HV | European | European | No causal effect | Protective factors: SA, HV | / |
| Huo, J, 2023 ( | Two-sample bidirectional MR | WMLs | European | European | No causal effect | No causal effect | / |
| Horton, M. K, 2023 ( | Two-sample unidirectional MR | MS | European | N/A | No causal effect | / | / |
| He, Q, 2023 ( | Two-sample bidirectional MR | Gut microbiota | European | European | N/A | N/A | N/A |
| Hua Xue, 2023 ( | Two-sample unidirectional MR | AD | European | European | No causal effect | / | / |
| Hui Zheng,2023 ( | Two-sample unidirectional MR | More years of schooling | European | European | / | Protective factors | More years of schooling-MOA: protective factor |
| Jin, C, 2023 ( | Two-sample unidirectional MR | Tea intake | European | European | / | No causal effect | No causal effect |
| Lei Zhao, 2023 ( | Two-sample bidirectional MR | WM | European | European | Established | Established | / |
| Mengmeng Wang, 2023 ( | Two-sample unidirectional MR | Ischemic stroke | European | European | No causal effect | / | No causal effect |
| Nike Zoe Welander, 2023 ( | Two-sample bidirectional MR | IBD, celiac disease | European | European | No causal effect | No causal effect | Celiac disease-MOA: protective factor |
| Tao Wei, 2023 ( | Two-sample unidirectional MR | Neuralized E3 ubiquitin-protein ligase 1 | European | European | / | Protective factor | / |
| Wenqiang Zhang, 2023 ( | Two-sample bidirectional MR | CKD | European | European and Japanese ancestries | No causal effect | No causal effect | / |
| Xinhui Liu, 2023 ( | Two-sample bidirectional MR | 83 dietary habits | European | European | Include only supported hypotheses | Include only supported hypotheses | / |
| Xiaofeng Lv, 2023 ( | Two-sample bidirectional MR | MDD | European | European | No causal effect | Risk factor | MDD-MWA: risk factor |
| Zhen-Ni Zhao, 2023 ( | Two-sample bidirectional MR | PD | European | European | No causal effect | No causal effect | / |
| Baranova, A, 2024 ( | Two-sample unidirectional MR | AD | European | European | Risk factor | / | / |
| Chengfeng Xu, 2024 ( | Two-sample unidirectional MR | AD | European | European | Risk factor | / | / |
| Chengcheng Zhang, 2024 ( | Two-sample unidirectional MR | Blood cis-eQTL, brain cis-eQTL | European | European | / | / | |
| Danfeng Xu, 2024 ( | Two-sample unidirectional MR | SLE | European | European | / | No causal effect | SLE-MWA: risk factor |
| Geng, C, 2024 ( | Two-sample bidirectional MR | AD | European | European | Risk factor | No causal effect | / |
| Guanglu Li, 2024 ( | Two-sample bidirectional MR | Psoriasis, T1D, RA, SLE, AR, asthma | European | European | No causal effect | No causal effect | No causal effect |
| Guoliang Zhu, 2024 ( | Two-sample bidirectional MR | Delayed AFS | European | European | Protective factor | Protective factor | MOA-AFS: protective factor |
| Hao Lv, 2024 ( | Two-sample bidirectional MR | AR | European | European | No causal effect | No causal effect | No causal effect |
| Hong, P, 2024 ( | Two-sample unidirectional MR | Lipid metabolism characteristics | European | European | / | / | / |
| Jianxiong Gui, 2024 ( | Two-sample unidirectional MR | TWAS | N/A | European | / | Protective factor: | / |
| Jareebi, Mohammad A, 2024 ( | Two-sample unidirectional MR | Smoking initiation, smoking intensity, maternal smoking, cheese intake, salad intake, coffee consumption, BMI, physical activity | European | European | / | Risk factor: maternal smoking | / |
| Jinjin Zhang, 2024 ( | Two-sample unidirectional MR | Coffee intake | European | European | / | Protective factor | Coffee intake-MWA: protective factor |
| Kang Qu, 2024 (1) ( | Two-sample bidirectional MR | Gut microbiota | European | European | No causal effect | Risk factor: | / |
| Kang Qu, 2024 (2) ( | Two-sample unidirectional MR | LDL-C, APOB, TC | European | European | / | No causal effect | / |
| Kangjia Zhang, 2024 ( | Two-sample bidirectional MR | MD | European | European | No causal effect | No causal effect | / |
| Lei Zhao, 2024 ( | Two-sample unidirectional MR | AD, VaD, FTD, LBD | European | European | Migraine-AD: risk factor | / | MOA-AD: risk factor |
| Meixuan Ren, 2024 ( | Two-sample unidirectional MR | SLE | European | European | / | / | SLE-MWA: risk factor |
| Peihong Li, 2024 ( | Two-sample unidirectional MR | SBs | European | European | / | Risk factor: watching TV | Watching TV-MOA: risk factor |
| Peng-Peng Niu, 2024 ( | Two-sample unidirectional MR | LRP11, ITIH1, ADGRF5 | European | European | / | Protective factors: LRP11, ADGRF5 | / |
| Xiangyue Meng, 2024 ( | Two-sample unidirectional MR | Gut microbiota | European (78%) | European | No causal effect | Risk factor: | / |
| Xu-Peng Wu, 2024 ( | Two-sample bidirectional MR | VTE | European | European | Risk factor | Risk factors | VTE-MWA: risk factor |
| Ya Li, 2024 ( | Two-sample unidirectional MR | Psoriasis | European | European | / | No causal effect | / |
| Yang Li, 2024 ( | Two-sample unidirectional MR | Depression, MDD, insomnia, sleep duration, short sleep duration, daytime sleepiness, napping | European | European | / | Risk factors: depression, MDD, insomnia | / |
| Yang Wang, 2024 ( | Two-sample bidirectional MR | VTE | European | European | Risk factors | Risk factors | / |
References
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
- Untitled
Used In Evidence Reviews
Similar Papers
Journal of sleep research · 2014
Sleep symptoms associated with intake of specific dietary nutrients.
Journal of neural transmission (Vienna, Austria : 1996) · 2020
Sleep and pain: recent insights, mechanisms, and future directions in the investigation of this relationship.
Diabetes care · 2020
Baseline Vitamin D Status, Sleep Patterns, and the Risk of Incident Type 2 Diabetes in Data From the UK Biobank Study.
International journal of environmental research and public health · 2022
Digital Addiction and Sleep.
PloS one · 2014
Serum nutritional biomarkers and their associations with sleep among US adults in recent national surveys.
Medical hypotheses · 2016